Proposal of a liver histology‐based scoring system for bile salt export pump deficiency. Issue 6 (25th March 2020)

• Record Type: Journal Article
• Authors: Zen, Yoh; Kondou, Hiroki; Nakazawa, Atsuko; Tanikawa, Ken; Hasegawa, Yasuhiro; Bessho, Kazuhiko; Imagawa, Kazuo; Ishige, Takashi; Inui, Ayano; Suzuki, Mitsuyoshi; Kasahara, Mureo; Yamamoto, Kouji; Yoshioka, Takako; Kage, Masayoshi; Hayashi, Hisamitsu
• Is Part Of: Hepatology research. Volume 50:Issue 6(2020)
• Page Start: 754
• Page End: 762
• Publication Date: 2020-03-25
• Subjects: BSEP -- clinical trial -- intrahepatic cholestasis -- liver biopsy -- NaPB -- PFIC; Liver -- Diseases -- Periodicals; Liver Diseases -- Periodicals; Foie -- Maladies -- Périodiques; 616.362
• DOI: 10.1111/hepr.13494
• Languages: English
• ISSNs: 1386-6346

Abstract

Abstract : Aim: Bile salt export pump (BSEP) deficiency manifests a form of progressive intrahepatic cholestasis. This study aimed to establish a scoring system of liver histology for the uncommon genetic condition. Methods: After a roundtable discussion and histology review, a scoring system for BSEP deficiency was established. Eleven tissue samples were independently evaluated by three pathologists based on the proposed standard for an interobserver agreement analysis. In four cases with serial tissue samples available, correlation between changes in histology scores and clinical outcome was examined. Results: Of 14 initially listed histopathological findings, 12 were selected for scoring and grouped into the following four categories: cholestasis, parenchymal changes, portal tract changes and fibrosis. Each category consisted of two to four microscopic findings that were further divided into three to six scores; therefore, each category had a maximum score of 8–11. Interobserver agreement was highest for pericellular fibrosis (κ = 0.849) and lowest for hepatocellular cholestasis (κ = 0.241) with the mean and median κ values of the 12 parameters being 0.561 and 0.602, respectively. For two patients whose clinical features worsened, score changes between two time points were interpreted as deteriorated. In two patients, who showed a good clinical response to preprandial treatment with sodium 4‐phenylbutyrate, histological changes were evaluated as improved or unchanged. Conclusions: The proposed histology‐based scoring system for BSEP deficiency with moderate interobserver agreement may be useful not only for monitoring microscopic changes in clinical practice but also for a surrogate endpoint in clinical trials.